Protalix BioTherapeutics Reports Third Quarter 2026 Financial and Business Results
Company to host conference call and webcast today at 8:00 a.m. ET Total revenues increased by $32.0 million year to date to $75.6 million, from $43.6 million for the same period in 2025 Net income was $4.0 million for the third quarter, up from $2.4 million in the third quarter of 2025,...
Covered in this story
Call it yourself
No calls on $PLX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Protalix Biotherapeutics Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.